LINDSAY LARSON: Open Payments
NPI 1558868281 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 62 payments from 10 companies in 2025. Trend: 2023 $49 · 2024 $612 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 30 | $399 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $246 |
| SANOFI-AVENTIS U.S. LLC | 5 | $134 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Philips North America LLC | 1 | $39 |
| ViiV Healthcare Company | 1 | $33 |
| Exact Sciences Corporation | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: INJECTAFER, XIFAXAN, TZIELD, APTIMA, Extended Holter, APRETUDE, Cologuard Collection Kit, JOURNAVX.
Industry payments across CA — which companies pay providers there.
